http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-100396-U
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8db95a750a64d4e05c01cf95f9649086 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B6-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate | 2015-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cb1016db9f65cfb8553105216e6f5ea http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_925ab76da3b22451e9f9943d9ea9c7a5 |
| publicationDate | 2015-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | UA-100396-U |
| titleOfInvention | METHOD OF FORECASTING FRAGMENT FRAGMENT |
| abstract | A method for predicting fracture fusion includes a clinical examination, radiography. In addition, methylene tetrahydrofolate reductase gene polymorphisms (MTHFR C677T), nitric oxide synthase (eNOS T 786), levels of osteocalcin and oligomeric matrix protein (COMP) are determined in the patient's blood serum. With homozygous carriage - 677-CC, 786-TT, osteocalcin levels - 17.2-38.0 ng / ml, СОМР - 531-595 ng / ml, fracture fusion is predicted. |
| priorityDate | 2015-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 79.